Biotrove Inc logo

BTRV - Biotrove Inc Share Price

n/a 0.0  0.0%

Last Trade -

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £3.46m
Position in Universe th / 6651
Bullish
Bearish
Unlock BTRV Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2002 2003 2004 2005 2006 2007 2008E 2009E CAGR / Avg
0.000 0.000 0.000 1.91 2.67 4.78 +58.2%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2007, BioTrove, Inc. revenues increased 79% to $4.8M. Net loss applicableto common stockholders increased 56% to $19.5M. Revenuesreflect OpenArray segment increase from $663K to $2.1M,RapidFire segment increase of 33% to $2.7M. Higher net lossreflects Corporate segment loss increase of 49% to $4.1M,OpenArray segment loss increase of 18% to $8.3M, RapidFiresegment income decrease of 48% to $233K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BTRV Revenue Unlock BTRV Revenue

Net Income

BTRV Net Income Unlock BTRV Revenue

Normalised EPS

BTRV Normalised EPS Unlock BTRV Revenue

PE Ratio Range

BTRV PE Ratio Range Unlock BTRV Revenue

Dividend Yield Range

BTRV Dividend Yield Range Unlock BTRV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BTRV EPS Forecasts Unlock BTRV Revenue
Profile Summary

BioTrove, Inc. develops, manufactures and markets instruments and consumables for genomic analysis, high-throughput screening and molecular diagnostics. The Company’s two marketed systems include OpenArray and RapidFire. Using micro- and nano-fluidic technologies, its products increase the speed exponentially, and decrease the cost of detecting and measuring deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), the genomic materials that store and transmit genetic information inside cells, as well as chemical compounds and proteins. Using its OpenArray or RapidFire systems, customers can design and conduct experiments of a scale and scope, which will provide benefits for the discovery, validation and commercialization processes. In December 2009, Life Technologies Corporation completed the acquisition of BioTrove, Inc.

Directors
Last Annual December 31st, 2007
Last Interim January 1st, 1970
Incorporated February 14, 2000
No. of Shareholders: 56
No. of Employees: 70
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange NASDAQ Global Market (Dual Listing)
Shares in Issue 2,310,017
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BTRV Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BTRV
Upcoming Events for BTRV
Frequently Asked Questions for Biotrove Inc
What is the Biotrove Inc share price?

As of , shares in Biotrove Inc are trading at n/a, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Biotrove Inc share price performed this year?

Shares in Biotrove Inc are currently trading at n/a and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biotrove Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Biotrove Inc?

There are no analysts currently covering Biotrove Inc.

When will Biotrove Inc next release its financial results?

It is not known when Biotrove Inc will next release financial results.

What is the Biotrove Inc dividend yield?

Biotrove Inc does not currently pay a dividend.

Does Biotrove Inc pay a dividend?

Biotrove Inc does not currently pay a dividend.

When does Biotrove Inc next pay dividends?

Biotrove Inc does not currently pay a dividend.

How do I buy Biotrove Inc shares?

To buy shares in Biotrove Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biotrove Inc?

Shares in Biotrove Inc are currently trading at n/a, giving the company a market capitalisation of £n/a.

Where are Biotrove Inc shares listed? Where are Biotrove Inc shares listed?

Here are the trading details for Biotrove Inc:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: BTRV
What kind of share is Biotrove Inc?

We were not able to load our ranking data for Biotrove Inc

Is there a Biotrove Inc share price forecast 2021?

We were not able to load any forecast data for Biotrove Inc.

How can I tell whether the Biotrove Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biotrove Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of n/a, shares in Biotrove Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biotrove Inc PE Ratio?

We were not able to find PE ratio data for Biotrove Inc.

Who are the key directors of Biotrove Inc?

Biotrove Inc's management team is headed by:

Albert Luderer - CEO
Robert Ellis - CHM
Jeffrey Leathe - CFO
Paul Pescatore - SVP
Edward Buzz Sztukowski - SVP
Michael Olex - VPR
Kevin Munnelly - VPR
Can Ozbal - VPR
Gregory Critchfield - NED
Enrico Petrillo - NED
Edward Erickson - NED
Guy Fish - DRC
Gary St. Pierre - VFN
Paul Cochran - SVP
Steven Gullans - DRC
Who are the major shareholders of Biotrove Inc?

Here are the top five shareholders of Biotrove Inc based on the size of their shareholding:

Similar to BTRV
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.